Are you or someone you know struggling with memory problems? We know how challenging that can be, and we're excited to share an opportunity that could make a difference. The TargetTau-1 Clinical Study is beginning, and we’re looking for participants to help test a promising new treatment. About the TargetTau-1 Study This study is designed…
KCA Neurology specializes in Alzheimer’s Dementia research and the clinic is growing to become a leading research institute in the area. We perform memory assessments on patients many times a day, and the number one question we receive is, “Is my memory loss normal for my age, or should I be concerned?” In many instances,…
Alzheimer's disease continues to be a significant challenge, affecting countless lives globally. However, with every challenge comes an opportunity. Today, we introduce the "Benfotiamine Alzheimer's Clinical Exploration (BACE) - ADC-061 Trial," a pioneering study that delves into the potential of Benfotiamine, a vitamin derivative, in treating Alzheimer's disease. By participating, you or your loved ones…
This article aims to provide comprehensive information about the trial, the therapeutic potential of Staccato Apomorphine, and its distinction from the currently available Apokyn."A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients with Established Parkinson’s Disease Experiencing OFF Episodes". What is Staccato Apomorphine (AZ-009)? Staccato Apomorphine…
A Groundbreaking Study Awaits Your Participation!
For those navigating the maze of Alzheimer's disease, it's not just memory loss that's a concern. Many patients with Alzheimer's also face the challenges of psychosis – symptoms like hallucinations or delusions that can be deeply distressing. And for their families and caregivers, watching a loved one grapple with these…
